Sign in
4

Changes in Ownership

Altimmune, Inc. Filed Acc 0001104659-23-009975

Chief Scientific Officer gave up 2,183 shares (to pay taxes)

  • Chief Scientific Officer acquired 1,436 shares (grant or award)
  • Chief Scientific Officer acquired 6,166 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roberts M Scot Chief Scientific Officer 2023-01-31 Grant or award +1,436 $10.21 $14,659 10,473 D: show line 1 in the form
Roberts M Scot Chief Scientific Officer 2023-02-01 Option exercise +6,166 16,639 D: show line 2 in the form
Roberts M Scot Chief Scientific Officer 2023-02-01 Shares withheld for taxes −2,183 $13.78 $30,082 14,456 D: show line 3 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Roberts M Scot Chief Scientific Officer 2023-02-01 Option exercise · Restricted Stock Units −6,166 12,332 D: show line 4 in the form
Loading xslF345X03/tm235311-4_4seq1.xml…